Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1993 Jun;48(6):611–614. doi: 10.1136/thx.48.6.611

Time course and duration of bronchodilatation with formoterol dry powder in patients with stable asthma.

A Wallin 1, T Sandström 1, L Rosenhall 1, B Melander 1
PMCID: PMC464582  PMID: 8346490

Abstract

BACKGROUND--Formoterol, a new beta 2 agonist, is long and fast acting when given as an aerosol. The aim was to determine the onset and duration of bronchodilatation with formoterol as a dry powder compared with salbutamol dry powder and with placebo. METHODS--Fifteen patients with stable asthma with a reversibility of 15% or more participated in a double blind, within patient study. On five different days the patients received formoterol 6 micrograms, 12 micrograms, or 24 micrograms, salbutamol 400 micrograms, or placebo in random order. Forced expiratory volume in one second (FEV1) was measured 10 minutes before, 30 minutes after, and then every hour for up to 12 hours after treatment. Specific airway resistance (sRaw) and specific airway conductance (sGaw) were measured immediately before and one, three, five, 10, 15, and 30 minutes after treatment. RESULTS--Formoterol 12 micrograms and 24 micrograms caused bronchodilatation as rapidly as salbutamol 400 micrograms. Peak values were not significantly different in the active treatments. The duration of action, calculated as median time with 20% or more of the maximum achieved increase in FEV1, was sustained for 9 hours and 16 minutes with salbutamol 400 micrograms, for 9 hours and 45 minutes with formoterol 6 micrograms, for 11 hours and 22 minutes with formoterol 12 micrograms, and for 11 hours and 42 minutes with formoterol 24 micrograms. CONCLUSIONS--Formoterol as a dry powder at doses of 12 micrograms and 24 micrograms produces a rapid onset of action and has a bronchodilator effect comparable with salbutamol 400 micrograms as a dry powder. The bronchodilatation was sustained for 11-12 hours. Formoterol 6 micrograms caused similar bronchodilatation but more slowly and for a shorter time.

Full text

PDF
611

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arvidsson P., Larsson S., Löfdahl C. G., Melander B., Svedmyr N., Wåhlander L. Inhaled formoterol during one year in asthma: a comparison with salbutamol. Eur Respir J. 1991 Nov;4(10):1168–1173. [PubMed] [Google Scholar]
  2. Arvidsson P., Larsson S., Löfdahl C. G., Melander B., Wåhlander L., Svedmyr N. Formoterol, a new long-acting bronchodilator for inhalation. Eur Respir J. 1989 Apr;2(4):325–330. [PubMed] [Google Scholar]
  3. Decker N., Quennedey M. C., Rouot B., Schwartz J., Velly J. Effects of N-aralkyl substitution of beta-agonists on alpha- and beta-adrenoceptor subtypes: pharmacological studies and binding assays. J Pharm Pharmacol. 1982 Feb;34(2):107–112. doi: 10.1111/j.2042-7158.1982.tb04195.x. [DOI] [PubMed] [Google Scholar]
  4. Derom E. Y., Pauwels R. A. Time course of bronchodilating effect of inhaled formoterol, a potent and long acting sympathomimetic. Thorax. 1992 Jan;47(1):30–33. doi: 10.1136/thx.47.1.30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Graff-Lonnevig V., Browaldh L. Twelve hours' bronchodilating effect of inhaled formoterol in children with asthma: a double-blind cross-over study versus salbutamol. Clin Exp Allergy. 1990 Jul;20(4):429–432. doi: 10.1111/j.1365-2222.1990.tb02805.x. [DOI] [PubMed] [Google Scholar]
  6. Ida H. Comparison of the action of BD 40 A and some other beta-adrenoceptor stimulants on the isolated trachea and atria of the guinea pig. Arzneimittelforschung. 1976;26(5):839–842. [PubMed] [Google Scholar]
  7. Kesten S., Chapman K. R., Broder I., Cartier A., Hyland R. H., Knight A., Malo J. L., Mazza J. A., Moote D. W., Small P. A three-month comparison of twice daily inhaled formoterol versus four times daily inhaled albuterol in the management of stable asthma. Am Rev Respir Dis. 1991 Sep;144(3 Pt 1):622–625. doi: 10.1164/ajrccm/144.3_Pt_1.622. [DOI] [PubMed] [Google Scholar]
  8. Löfdahl C. G., Svedmyr N. Formoterol fumarate, a new beta 2-adrenoceptor agonist. Acute studies of selectivity and duration of effect after inhaled and oral administration. Allergy. 1989 May;44(4):264–271. doi: 10.1111/j.1398-9995.1989.tb01068.x. [DOI] [PubMed] [Google Scholar]
  9. Maesen F. P., Smeets J. J., Gubbelmans H. L., Zweers P. G. Bronchodilator effect of inhaled formoterol vs salbutamol over 12 hours. Chest. 1990 Mar;97(3):590–594. doi: 10.1378/chest.97.3.590. [DOI] [PubMed] [Google Scholar]
  10. Wallin A., Melander B., Rosenhall L., Sandström T., Wåhlander L. Formoterol, a new long acting beta 2 agonist for inhalation twice daily, compared with salbutamol in the treatment of asthma. Thorax. 1990 Apr;45(4):259–261. doi: 10.1136/thx.45.4.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Wegener T., Hedenström H., Melander B. Rapid onset of action of inhaled formoterol in asthmatic patients. Chest. 1992 Aug;102(2):535–538. doi: 10.1378/chest.102.2.535. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES